CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
  • About
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

Weekly Brief

Subscribe

THANK YOU FOR SUBSCRIBING

loading

Weekly Brief

Thursday, May 12,2022

Feature of the Week

Efficacy and Safety Data by Entasis Therapeutics from Landmark Phase 3 Attack Trial
Dr. Alita Miller, Vice President, Microbiology, discussed the characterization of Acinetobacter baumannii-calcoaceticus  Read more ‣
How Does Biotechnology Help Humans?
The technological advancement in the biotechnology sector has reached a dizzying milestone in recent years. Rapid advances in this sector, ranging from biosensors to 3D bioprinting and gene editing to VR and AR  Read more ‣
The several benefits Of Agricultural Genome Editing
Genome editing can help boost a wide variety of crops that can resist heat, floods, salinity, drought, and extreme cold.  Read more ‣

Industry Contributors

Aligning IT with the Cadence of your Business
By William Leonard, ScD, Chief Information Officer, MPI Research  
 Read more ‣
Technology Enables Patient Empowerment
By  
We are entering a time of dramatic transformation within medical care with a focus on technology. Every clinician I speak with expresses elevating needs and expectations for how technology will support them in care delivery.  Read more ‣
THE FUTURE OF IMMUNOTHERAPY: CAR T CELLS
By Derya DİLEK KANÇAĞI, PhD, Laboratory Manager, Acıbadem Labcell Cellular Therapy Center  
Cancer disease, which is increasing in society today, is a great concern....  Read more ‣
Encouraging Innovation in Healthcare in a COVID - 19 World
By Duncan Turner, General Partner, SOSV, Managing Director, HAX  
The last few months have created unimaginable changes in our world. HAX, with our largest hub located...  Read more ‣

Featured Vendors

DelNova: Advanced Therapeutics for Botulinum Toxin Complications
By Mary Gardner, Founder and CEO  
In 2016, Mary Gardner, the Founder and CEO,laid the foundation of DelNova. It is the only company in the industry that is developing a feasible solution, ReViVox™, to address botulinum toxin type A complications following aesthetic and medical...  Read more ‣
Alamab Therapeutics: Innovative First-in-Class Antibody Drugs
By Dr. Qingxi (Charles) Wang, Chairman  
AlaMab Therapeutics has emerged as a pioneer in developing novel, first-in-class antibody drugs. The company devotes a significant amount of time in educating the regulatory agency and their present and potential investors about their drug target....  Read more ‣
Clario: Unlocking the Richest Clinical Evidence with Science-driven Solutions
By Joe Eazor, President and CEO  
Led by science and technology thought leaders, visionaries, and master clinical trial management experts, the company diligently supports regulatory compliance across 120 countries  Read more ‣

Copyright © 2022 Life Science Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/newsletter/